Literature DB >> 22368721

Functional bowel disorders in adults.

Winfried Häuser1, Peter Layer, Peter Henningsen, Wolfgang Kruis.   

Abstract

BACKGROUND: Chronic abdominal pain, bloating, constipation, diarrhea, and stool irregularity are common symptoms in primary care and gastroenterology. A routine diagnostic evaluation fails to reveal any underlying somatic condition in about half of the affected patients, who are therefore said to have a functional bowel disorder. Physicians are often unsure how extensive the work-up must be to exclude a somatic cause.
METHODS: This review is based on a selective review of the literature, including published guidelines from Germany and abroad.
RESULTS: Functional bowel disorders are diagnosed on the basis of a typical constellation of symptoms and the absence of pathological findings that would adequately explain them (exclusive criteria). The basic diagnostic assessment, consisting of a physical examination, basic laboratory tests, abdominal ultrasonography, and (in women) a gynecological examination, is supplemented by further testing that depends on the patient's symptoms. Colonoscopy is obligatory to rule out underlying pathological abnormalities. By communicating the diagnosis of irritable bowel syndrome to the patient, the physician shows that the patient's symptoms and concerns have been taken seriously. The mainstays of treatment are patient education on the benign course of the disease and the encouragement of a salubrious lifestyle. Further treatment options include dietary measures, time-limited symptomatic treatment with drugs, and psychotherapy.
CONCLUSION: The diagnosis of a functional bowel disorder is based on a thorough history (positive criteria) and a small battery of diagnostic tests to exclude somatic disease. Both the diagnostic assessment and the treatment should be carried out in accordance with published guidelines.

Entities:  

Mesh:

Year:  2012        PMID: 22368721      PMCID: PMC3285279          DOI: 10.3238/arztebl.2012.0083

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  42 in total

1.  Irritable bowel syndrome--the main recommendations.

Authors:  Viola Andresen; Jutta Keller; Christian Pehl; Michael Schemann; Jan Preiss; Peter Layer
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

2.  The clinical course and prognostic determinants of the irritable bowel syndrome: a literature review.

Authors:  H A Janssen; J W Muris; J A Knotterus
Journal:  Scand J Gastroenterol       Date:  1998-06       Impact factor: 2.423

Review 3.  Recurrent abdominal pain in childhood.

Authors:  Philip Bufler; Martina Gross; Holm H Uhlig
Journal:  Dtsch Arztebl Int       Date:  2011-04-29       Impact factor: 5.594

4.  Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts.

Authors:  Brennan M R Spiegel; Mary Farid; Eric Esrailian; Jennifer Talley; Lin Chang
Journal:  Am J Gastroenterol       Date:  2010-03-02       Impact factor: 10.864

Review 5.  Functional gallbladder and sphincter of oddi disorders.

Authors:  Jose Behar; Enrico Corazziari; Moises Guelrud; Walter Hogan; Stuart Sherman; James Toouli
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 6.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 7.  Irritable bowel syndrome in general practice: an overview.

Authors:  A H Oberndorff-Klein Woolthuis; R J M Brummer; N J de Wit; J W M Muris; R W Stockbrügger
Journal:  Scand J Gastroenterol Suppl       Date:  2004

Review 8.  Doctor-patient interaction for irritable bowel syndrome in primary care: a systematic perspective.

Authors:  Surinder K Dhaliwal; Richard H Hunt
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-11       Impact factor: 2.566

9.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

Review 10.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

View more
  12 in total

1.  Correspondence (letter to the editor): Diamine oxidase deficiency.

Authors:  Eckhard Buchheim
Journal:  Dtsch Arztebl Int       Date:  2012-06-22       Impact factor: 5.594

2.  Correspondence (letter to the editor): Uncritical assessment.

Authors:  Bernhard Lache
Journal:  Dtsch Arztebl Int       Date:  2012-06-22       Impact factor: 5.594

3.  Correspondence (letter to the editor): Thinking outside the box.

Authors:  Eduard Rosler
Journal:  Dtsch Arztebl Int       Date:  2012-06-22       Impact factor: 5.594

Review 4.  [Visceral pain].

Authors:  S Elsenbruch; W Häuser; W Jänig
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

5.  Annular pancreas in a 24-year-old woman with persistent abdominal pain.

Authors:  Randolph de la Rosa Rodriguez; Alexandra Fogarty; Gary M Israel; Mayra J Sanchez
Journal:  BMJ Case Rep       Date:  2019-06-20

6.  The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome.

Authors:  Winfried Häuser; Ursula Marschall; Peter Layer; Thomas Grobe
Journal:  Dtsch Arztebl Int       Date:  2019-07-08       Impact factor: 5.594

7.  Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease.

Authors:  Mahsa Jalili; Azita Hekmatdoost; Homayoon Vahedi; Hossein Poustchi; Behnam Khademi; Mohsen Saadi; Maryam Zemestani; Leila Janani
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

8.  Design and validation of a German version of the GSRS-IBS - an analysis of its psychometric quality and factorial structure.

Authors:  Sarah K Schäfer; Kathrin Julia Weidner; Jorge Hoppner; Nicolas Becker; Dana Friedrich; Caroline S Stokes; Frank Lammert; Volker Köllner
Journal:  BMC Gastroenterol       Date:  2017-12-04       Impact factor: 3.067

9.  Functional gastrointestinal disorders negatively affect health-related quality of life in MS.

Authors:  Ruth Ann Marrie; Stella Leung; Tuula Tyry; Gary R Cutter; Robert Fox; Amber Salter
Journal:  Neurol Clin Pract       Date:  2019-10

10.  Patients with Multiple Functional Gastrointestinal Disorders (FGIDs) Show Increased Illness Severity: A Cross-Sectional Study in a Tertiary Care FGID Specialty Clinic.

Authors:  Sabrina Berens; Felicitas Engel; Annika Gauss; Jonas Tesarz; Wolfgang Herzog; Beate Niesler; Esther Stroe-Kunold; Rainer Schaefert
Journal:  Gastroenterol Res Pract       Date:  2020-01-28       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.